Keywords: novartis, sebivo, gains, domestic, approval, swiss, drug

Novartis' Sebivo gains domestic approval

Article | 02 October 2006

Print This

Swiss drug major Novartis' Sebivo (telbivudine), a new treatment for patients with chronic hepatitis B, has been cleared in Switzerland. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in